Table of Contents Global Cancer Supportive Care Medicine Market by Manufacturers, Regions, Type and Application, Forecast to 2023 1 Market Overview 1.1 Cancer Supportive Care Medicine Introduction 1.2 Market Analysis by Type 1.2.1 Antiemetic Drugs 1.2.2 Erythropoietin-Stimulating Agents 1.2.3 Granulocyte-Stimulating Agents 1.2.4 Analgesics 1.2.5 ????Others 1.3 Market Analysis by Applications 1.3.1 Chemotherapy-Induced Anemia 1.3.2 CINV 1.3.3 Bone Metastasis 1.3.4 Cancer Pain 1.3.5 Other 1.4 New Project SWOT Analysis of Cancer Supportive Care Medicine 1.5 Industry News Analysis of Cancer Supportive Care Medicine 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Cancer Supportive Care Medicine 2.2 Raw Material Analysis of Cancer Supportive Care Medicine 2.2.1 Raw Material A Market Analysis 2.2.2 Raw Material B Market Analysis 2.2.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Cancer Supportive Care Medicine 2.4 Other Costs Analysis of Cancer Supportive Care Medicine 2.5 Manufacturing Cost Structure Analysis of Cancer Supportive Care Medicine 2.6 Manufacturing Process Analysis of Cancer Supportive Care Medicine 2.7 Raw Materials Sources of Cancer Supportive Care Medicine Major Manufacturers in 2017 2.8 Downstream Buyers of Cancer Supportive Care Medicine 3 Global Cancer Supportive Care Medicine Players Profiles and Sales Data 3.1 Amgen 3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.1.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.1.2.1 Antiemetic Drugs 3.1.2.2 Erythropoietin-Stimulating Agents 3.1.2.3 Granulocyte-Stimulating Agents 3.1.3 Amgen Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Amgen Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 Amgen Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.2 Helsinn Healthcare 3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.2.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.2.2.1 Antiemetic Drugs 3.2.2.2 Erythropoietin-Stimulating Agents 3.2.2.3 Granulocyte-Stimulating Agents 3.2.3 Helsinn Healthcare Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Helsinn Healthcare Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 Helsinn Healthcare Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.3 Johnson &Johnson 3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.3.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.3.2.1 Antiemetic Drugs 3.3.2.2 Erythropoietin-Stimulating Agents 3.3.2.3 Granulocyte-Stimulating Agents 3.3.3 Johnson &Johnson Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Johnson &Johnson Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 Johnson &Johnson Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.4 Merck 3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.4.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.4.2.1 Antiemetic Drugs 3.4.2.2 Erythropoietin-Stimulating Agents 3.4.2.3 Granulocyte-Stimulating Agents 3.4.3 Merck Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Merck Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Merck Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.5 F. Hoffmann-La Roche 3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.5.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.5.2.1 Antiemetic Drugs 3.5.2.2 Erythropoietin-Stimulating Agents 3.5.2.3 Granulocyte-Stimulating Agents 3.5.3 F. Hoffmann-La Roche Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 F. Hoffmann-La Roche Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 F. Hoffmann-La Roche Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.6 GlaxoSmithKline 3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.6.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.6.2.1 Antiemetic Drugs 3.6.2.2 Erythropoietin-Stimulating Agents 3.6.2.3 Granulocyte-Stimulating Agents 3.6.3 GlaxoSmithKline Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 GlaxoSmithKline Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 GlaxoSmithKline Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.7 Heron Therapeutics 3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.7.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.7.2.1 Antiemetic Drugs 3.7.2.2 Erythropoietin-Stimulating Agents 3.7.2.3 Granulocyte-Stimulating Agents 3.7.3 Heron Therapeutics Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Heron Therapeutics Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 Heron Therapeutics Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.8 Kyowa Hakko Kirin 3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.8.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.8.2.1 Antiemetic Drugs 3.8.2.2 Erythropoietin-Stimulating Agents 3.8.2.3 Granulocyte-Stimulating Agents 3.8.3 Kyowa Hakko Kirin Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 Kyowa Hakko Kirin Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 Kyowa Hakko Kirin Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.9 Novartis 3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.9.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.9.2.1 Antiemetic Drugs 3.9.2.2 Erythropoietin-Stimulating Agents 3.9.2.3 Granulocyte-Stimulating Agents 3.9.3 Novartis Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Novartis Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.9.5 Novartis Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.10 TESARO 3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.10.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.10.2.1 Antiemetic Drugs 3.10.2.2 Erythropoietin-Stimulating Agents 3.10.2.3 Granulocyte-Stimulating Agents 3.10.3 TESARO Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 TESARO Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.10.5 TESARO Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.11 Teva Pharmaceutical Industries 4 Global Cancer Supportive Care Medicine Market Competition by Manufacturers 4.1 Global Cancer Supportive Care Medicine Sales and Share by Manufacturers (2012-2017) 4.2 Global Cancer Supportive Care Medicine Revenue (Million USD) and Share (%) by Manufacturers (2012-2017) 4.3 Market Concentration Rate 4.3.1 Top 3 Cancer Supportive Care Medicine Manufacturer Market Share 4.3.2 Top 6 Cancer Supportive Care Medicine Manufacturer Market Share 4.4 Market Competition Trend 5 Global Cancer Supportive Care Medicine Market Analysis by Regions 5.1 Global Cancer Supportive Care Medicine Sales, Revenue and Market Share by Regions 5.1.1 Global Cancer Supportive Care Medicine Sales by Regions (2012-2017) 5.1.2 Global Cancer Supportive Care Medicine Revenue by Regions (2012-2017) 5.2 North America Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) 5.3 Europe Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) 5.4 Asia-Pacific Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) 5.5 South America Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) 5.6 Middle East and Africa Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) 6 North America Cancer Supportive Care Medicine by Countries 6.1 North America Cancer Supportive Care Medicine Sales, Revenue and Market Share by Countries 6.1.1 North America Cancer Supportive Care Medicine Sales by Countries (2012-2017) 6.1.2 North America Cancer Supportive Care Medicine Revenue by Countries (2012-2017) 6.2 United States Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) 6.3 Canada Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) 6.4 Mexico Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) 7 Europe Cancer Supportive Care Medicine by Countries 7.1 North America Cancer Supportive Care Medicine Sales, Revenue and Market Share by Countries 7.1.1 Europe Cancer Supportive Care Medicine Sales by Countries (2012-2017) 7.1.2 Europe Cancer Supportive Care Medicine Sales by Countries (2012-2017) 7.2 Germany Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) 7.3 France Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) 7.4 UK Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) 7.5 Russia Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) 7.6 Italy Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) 8 Asia-Pacific Cancer Supportive Care Medicine by Countries 8.1 Asia-Pacific Cancer Supportive Care Medicine Sales, Revenue and Market Share by Countries 8.1.1 Asia-Pacific Cancer Supportive Care Medicine Sales by Countries (2012-2017) 8.1.2 Asia-Pacific Cancer Supportive Care Medicine Sales by Countries (2012-2017) 8.2 China Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) 8.3 Japan Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) 8.4 Korea Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) 8.5 India Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) 8.6 Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) 9 South America Cancer Supportive Care Medicine by Countries 9.1 South America Cancer Supportive Care Medicine Sales, Revenue and Market Share by Countries 9.1.1 South America Cancer Supportive Care Medicine Sales by Countries (2012-2017) 9.1.2 South America Cancer Supportive Care Medicine Sales by Countries (2012-2017) 9.2 Brazil Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) 9.3 Argentina Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) 9.4 Columbia Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) 10 Middle East and Africa Cancer Supportive Care Medicine by Countries 10.1 Middle East and Africa Cancer Supportive Care Medicine Sales, Revenue and Market Share by Countries 10.1.1 Middle East and Africa Cancer Supportive Care Medicine Sales by Countries (2012-2017) 10.1.2 Middle East and Africa Cancer Supportive Care Medicine Sales by Countries (2012-2017) 10.2 Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) 10.3 UAE Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) 10.4 Egypt Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) 10.5 Nigeria Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) 10.6 South Africa Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) 11 Global Cancer Supportive Care Medicine Market Segment by Type 11.1 Global Cancer Supportive Care Medicine Sales, Revenue and Market Share by Type (2012-2017) 11.1.1 Global Cancer Supportive Care Medicine Sales and Market Share by Type (2012-2017) 11.1.2 Global Cancer Supportive Care Medicine Revenue and Market Share by Type (2012-2017) 11.2 Antiemetic Drugs Sales Growth Rate and Price 11.2.1 Global Antiemetic Drugs Sales Growth Rate (2012-2017) 11.2.2 Global Antiemetic Drugs Price (2012-2017) 11.3 Erythropoietin-Stimulating Agents Sales Growth Rate and Price 11.3.1 Global Erythropoietin-Stimulating Agents Sales Growth Rate (2012-2017) 11.3.2 Global Erythropoietin-Stimulating Agents Price (2012-2017) 11.4 Granulocyte-Stimulating Agents Sales Growth Rate and Price 11.4.1 Global Granulocyte-Stimulating Agents Sales Growth Rate (2012-2017) 11.4.2 Global Granulocyte-Stimulating Agents Price (2012-2017) 11.5 Analgesics Sales Growth Rate and Price 11.5.1 Global Analgesics Sales Growth Rate (2012-2017) 11.5.2 Global Analgesics Price (2012-2017) 11.6 Others Sales Growth Rate and Price 11.6.1 Global Others Sales Growth Rate (2012-2017) 11.6.2 Global Others Price (2012-2017) 12 Global Cancer Supportive Care Medicine by Application 12.1 Global Cancer Supportive Care Medicine Sales Market Share by Application (2012-2017) 12.2 Chemotherapy-Induced Anemia Sales Growth Rate (2012-2017) 12.3 CINV Sales Growth Rate (2012-2017) 12.4 Bone Metastasis Sales Growth Rate (2012-2017) 12.5 Cancer Pain Sales Growth Rate (2012-2017) 12.6 Other Sales Growth Rate (2012-2017) 13 Global Cancer Supportive Care Medicine Market Forecast (2018-2023) 13.1 Global Cancer Supportive Care Medicine Sales Volume, Revenue and Price Forecast (2018-2023) 13.1.1 Global Cancer Supportive Care Medicine Sales Volume and Growth Rate Forecast (2018-2023) 13.1.2 Global Cancer Supportive Care Medicine Revenue and Growth Rate Forecast (2018-2023) 13.1.3 Global Cancer Supportive Care Medicine Price and Trend Forecast (2018-2023) 13.2 Global Cancer Supportive Care Medicine Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.1 Global Cancer Supportive Care Medicine Sales Volume and Growth Rate Forecast by Regions (2018-2023) 13.2.2 Global Cancer Supportive Care Medicine Revenue and Growth Rate Forecast by Regions (2018-2023) 13.2.3 Global Cancer Supportive Care Medicine market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Cancer Supportive Care Medicine Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.2.4 North America (United States, Canada and Mexico) Cancer Supportive Care Medicine Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.2.5 Europe (Germany, France, UK, Russia and Italy) Cancer Supportive Care Medicine Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.2.6 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Supportive Care Medicine Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.2.7 South America (Brazil, Argentina, Columbia) Cancer Supportive Care Medicine Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.2.8 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Supportive Care Medicine Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.3 Global Cancer Supportive Care Medicine Sales Volume, Revenue and Price Forecast by Type (2018-2023) 13.3.1 Global Cancer Supportive Care Medicine Sales Forecast by Type (2018-2023) 13.3.2 Global Cancer Supportive Care Medicine Revenue Forecast by Type (2018-2023) 13.3.3 Global Cancer Supportive Care Medicine Price Forecast by Type (2018-2023) 13.4 Global Cancer Supportive Care Medicine Sales Volume Forecast by Application (2018-2023) 13.4.1 Global Cancer Supportive Care Medicine Sales Forecast by Application (2018-2023) 13.4.2 Global Cancer Supportive Care Medicine Market Share Forecast by Application (2018-2023) 14 Sales Channel, Distributors, Traders and Dealers 14.1 Sales Channel 14.1.1 Direct Marketing 14.1.2 Indirect Marketing 14.1.3 Marketing Channel Future Trend 14.2 Distributors, Traders and Dealers 15 Research Findings and Conclusion 16 Appendix 16.1 Methodology/Research Approach 16.2 Analyst Introduction 16.3 Data Source

List of Tables and Figures Figure Cancer Supportive Care Medicine Picture Table Product Specifications of Cancer Supportive Care Medicine Figure Global Sales Market Share of Cancer Supportive Care Medicine by Types in 2017 Table Cancer Supportive Care Medicine Types for Major Manufacturers Figure Antiemetic Drugs Picture Figure Erythropoietin-Stimulating Agents Picture Figure Granulocyte-Stimulating Agents Picture Figure Analgesics Picture Figure Others Picture Figure Cancer Supportive Care Medicine Sales Market Share by Applications in 2017 Figure Chemotherapy-Induced Anemia Picture Figure CINV Picture Figure Bone Metastasis Picture Figure Cancer Pain Picture Figure Other Picture Figure New Project SWOT Analysis of Cancer Supportive Care Medicine Table Industry News List of Cancer Supportive Care Medicine Figure Industry Chain Structure of Cancer Supportive Care Medicine Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Cancer Supportive Care Medicine in 2017 Figure Manufacturing Process Analysis of Cancer Supportive Care Medicine Table Raw Materials Sources of Cancer Supportive Care Medicine Major Manufacturers in 2017 Table Major Buyers of Cancer Supportive Care Medicine Table Amgen Basic Information List Table Amgen Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Amgen Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure Amgen Cancer Supportive Care Medicine Sales Global Market Share (%) (2012-2017) Figure Amgen Cancer Supportive Care Medicine Revenue Global Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Amgen Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share Table Amgen Cancer Supportive Care Medicine Volume in CINV and Its Application Share Table Amgen Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share Table Helsinn Healthcare Basic Information List Table Helsinn Healthcare Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Helsinn Healthcare Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure Helsinn Healthcare Cancer Supportive Care Medicine Sales Global Market Share (%) (2012-2017) Figure Helsinn Healthcare Cancer Supportive Care Medicine Revenue Global Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Helsinn Healthcare Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share Table Helsinn Healthcare Cancer Supportive Care Medicine Volume in CINV and Its Application Share Table Helsinn Healthcare Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share Table Johnson &Johnson Basic Information List Table Johnson &Johnson Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Johnson &Johnson Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure Johnson &Johnson Cancer Supportive Care Medicine Sales Global Market Share (%) (2012-2017) Figure Johnson &Johnson Cancer Supportive Care Medicine Revenue Global Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Johnson &Johnson Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share Table Johnson &Johnson Cancer Supportive Care Medicine Volume in CINV and Its Application Share Table Johnson &Johnson Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share Table Merck Basic Information List Table Merck Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Merck Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure Merck Cancer Supportive Care Medicine Sales Global Market Share (%) (2012-2017) Figure Merck Cancer Supportive Care Medicine Revenue Global Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Merck Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share Table Merck Cancer Supportive Care Medicine Volume in CINV and Its Application Share Table Merck Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share Table F. Hoffmann-La Roche Basic Information List Table F. Hoffmann-La Roche Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure F. Hoffmann-La Roche Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure F. Hoffmann-La Roche Cancer Supportive Care Medicine Sales Global Market Share (%) (2012-2017) Figure F. Hoffmann-La Roche Cancer Supportive Care Medicine Revenue Global Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table F. Hoffmann-La Roche Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share Table F. Hoffmann-La Roche Cancer Supportive Care Medicine Volume in CINV and Its Application Share Table F. Hoffmann-La Roche Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share Table GlaxoSmithKline Basic Information List Table GlaxoSmithKline Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure GlaxoSmithKline Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure GlaxoSmithKline Cancer Supportive Care Medicine Sales Global Market Share (%) (2012-2017) Figure GlaxoSmithKline Cancer Supportive Care Medicine Revenue Global Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table GlaxoSmithKline Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share Table GlaxoSmithKline Cancer Supportive Care Medicine Volume in CINV and Its Application Share Table GlaxoSmithKline Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share Table Heron Therapeutics Basic Information List Table Heron Therapeutics Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Heron Therapeutics Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure Heron Therapeutics Cancer Supportive Care Medicine Sales Global Market Share (%) (2012-2017) Figure Heron Therapeutics Cancer Supportive Care Medicine Revenue Global Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Heron Therapeutics Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share Table Heron Therapeutics Cancer Supportive Care Medicine Volume in CINV and Its Application Share Table Heron Therapeutics Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share Table Kyowa Hakko Kirin Basic Information List Table Kyowa Hakko Kirin Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Kyowa Hakko Kirin Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure Kyowa Hakko Kirin Cancer Supportive Care Medicine Sales Global Market Share (%) (2012-2017) Figure Kyowa Hakko Kirin Cancer Supportive Care Medicine Revenue Global Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Kyowa Hakko Kirin Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share Table Kyowa Hakko Kirin Cancer Supportive Care Medicine Volume in CINV and Its Application Share Table Kyowa Hakko Kirin Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share Table Novartis Basic Information List Table Novartis Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Novartis Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure Novartis Cancer Supportive Care Medicine Sales Global Market Share (%) (2012-2017) Figure Novartis Cancer Supportive Care Medicine Revenue Global Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Novartis Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share Table Novartis Cancer Supportive Care Medicine Volume in CINV and Its Application Share Table Novartis Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share Table TESARO Basic Information List Table TESARO Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure TESARO Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure TESARO Cancer Supportive Care Medicine Sales Global Market Share (%) (2012-2017) Figure TESARO Cancer Supportive Care Medicine Revenue Global Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table TESARO Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share Table TESARO Cancer Supportive Care Medicine Volume in CINV and Its Application Share Table TESARO Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share Table Global Cancer Supportive Care Medicine Sales by Manufacturer (2016-2017) Figure Global Cancer Supportive Care Medicine Sales Market Share by Manufacturer in 2016 Figure Global Cancer Supportive Care Medicine Sales Market Share by Manufacturer in 2017 Table Global Cancer Supportive Care Medicine Revenue by Manufacturer (2016-2017) Figure Global Cancer Supportive Care Medicine Revenue Market Share by Manufacturer in 2016 Figure Global Cancer Supportive Care Medicine Revenue Market Share by Manufacturer in 2017 Figure Top 3 Cancer Supportive Care Medicine Manufacturer (Revenue) Market Share in 2017 Figure Top 6 Cancer Supportive Care Medicine Manufacturer (Revenue) Market Share in 2017 Figure Global Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) Figure Global Cancer Supportive Care Medicine Revenue and Growth Rate (2012-2017) Table Global Cancer Supportive Care Medicine Sales by Regions (2012-2017) Table Global Cancer Supportive Care Medicine Sales Market Share by Regions (2012-2017) Table Global Cancer Supportive Care Medicine Revenue by Regions (2012-2017) Table Global Cancer Supportive Care Medicine Revenue Market Share by Regions in 2012 Table Global Cancer Supportive Care Medicine Revenue Market Share by Regions in 2017 Figure North America Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) Figure Europe Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) Figure Asia-Pacific Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) Figure South America Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) Figure Middle East and Africa Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) Figure North America Cancer Supportive Care Medicine Revenue and Growth Rate (2012-2017) Table North America Cancer Supportive Care Medicine Sales by Countries (2012-2017) Table North America Cancer Supportive Care Medicine Sales Market Share by Countries (2012-2017) Figure North America Cancer Supportive Care Medicine Sales Market Share by Countries in 2012 Figure North America Cancer Supportive Care Medicine Sales Market Share by Countries in 2017 Table North America Cancer Supportive Care Medicine Revenue by Countries (2012-2017) Table North America Cancer Supportive Care Medicine Revenue Market Share by Countries (2012-2017) Figure North America Cancer Supportive Care Medicine Revenue Market Share by Countries in 2012 Figure North America Cancer Supportive Care Medicine Revenue Market Share by Countries in 2017 Figure United States Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) Figure Canada Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) Figure Mexico Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) Figure Europe Cancer Supportive Care Medicine Revenue and Growth Rate (2012-2017) Table Europe Cancer Supportive Care Medicine Sales by Countries (2012-2017) Table Europe Cancer Supportive Care Medicine Sales Market Share by Countries (2012-2017) Table Europe Cancer Supportive Care Medicine Revenue by Countries (2012-2017) Table Europe Cancer Supportive Care Medicine Revenue Market Share by Countries in 2012 Table Europe Cancer Supportive Care Medicine Revenue Market Share by Countries in 2017 Figure Germany Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) Figure UK Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) Figure France Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) Figure Russia Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) Figure Italy Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) Figure Asia-Pacific Cancer Supportive Care Medicine Revenue and Growth Rate (2012-2017) Table Asia-Pacific Cancer Supportive Care Medicine Sales by Countries (2012-2017) Table Asia-Pacific Cancer Supportive Care Medicine Sales Market Share by Countries (2012-2017) Table Asia-Pacific Cancer Supportive Care Medicine Sales Market Share by Countries (2012-2017) Table Asia-Pacific Cancer Supportive Care Medicine Revenue by Countries (2012-2017) Table Asia-Pacific Cancer Supportive Care Medicine Revenue Market Share by Countries (2012-2017) Figure China Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) Figure Japan Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) Figure Korea Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) Figure India Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) Figure Southeast Asia Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) Figure South America Cancer Supportive Care Medicine Revenue and Growth Rate (2012-2017) Table South America Cancer Supportive Care Medicine Sales by Countries (2012-2017) Table South America Cancer Supportive Care Medicine Sales Market Share by Countries (2012-2017) Figure South America Cancer Supportive Care Medicine Sales Market Share by Countries in 2017 Table South America Cancer Supportive Care Medicine Revenue by Countries (2012-2017) Table South America Cancer Supportive Care Medicine Revenue Market Share by Countries (2012-2017) Figure South America Cancer Supportive Care Medicine Revenue Market Share by Countries in 2017 Figure Brazil Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) Figure Argentina Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) Figure Columbia Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) Figure Middle East and Africa Cancer Supportive Care Medicine Revenue and Growth Rate (2012-2017) Table Middle East and Africa Cancer Supportive Care Medicine Sales by Countries (2012-2017) Table Middle East and Africa Cancer Supportive Care Medicine Sales Market Share by Countries (2012-2017) Figure Middle East and Africa Cancer Supportive Care Medicine Sales Market Share by Countries in 2017 Table Middle East and Africa Cancer Supportive Care Medicine Revenue by Countries (2012-2017) Table Middle East and Africa Cancer Supportive Care Medicine Revenue Market Share by Countries (2012-2017) Figure Middle East and Africa Cancer Supportive Care Medicine Revenue Market Share by Countries in 2012 Figure Middle East and Africa Cancer Supportive Care Medicine Revenue Market Share by Countries in 2017 Figure Saudi Arabia Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) Figure UAE Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) Figure Egypt Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) Figure Nigeria Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) Figure South Africa Cancer Supportive Care Medicine Sales and Growth Rate (2012-2017) Table Global Cancer Supportive Care Medicine Sales by Type (2012-2017) Table Global Cancer Supportive Care Medicine Sales Share by Type (2012-2017) Table Global Cancer Supportive Care Medicine Revenue by Type (2012-2017) Table Global Cancer Supportive Care Medicine Revenue Share by Type (2012-2017) Figure Global Antiemetic Drugs Sales Growth Rate (2012-2017) Figure Global Antiemetic Drugs Sales Price (2012-2018) Figure Global Antiemetic Drugs Sales Growth Rate (2012-2017) Figure Global Erythropoietin-Stimulating Agents Sales Price (2012-2018) Figure Global Granulocyte-Stimulating Agents Sales Growth Rate (2012-2017) Figure Global Granulocyte-Stimulating Agents Sales Price (2012-2018) Figure Global Analgesics Sales Growth Rate (2012-2017) Figure Global Analgesics Sales Growth Rate (2012-2018) Figure Global Others Sales Growth Rate (2012-2017) Figure Global Others Sales Price (2012-2018) Table Global Cancer Supportive Care Medicine Sales by Application (2012-2017) Table Global Cancer Supportive Care Medicine Sales Share by Application (2012-2017) Figure Global Chemotherapy-Induced Anemia Sales Growth Rate (2012-2017) Figure Global CINV Sales Growth Rate (2012-2017) Figure Global Bone Metastasis Sales Growth Rate (2012-2019) Figure Global Cancer Pain Sales Growth Rate (2012-2020) Figure Global Other Sales Growth Rate (2012-2021) Figure Global Cancer Supportive Care Medicine Sales, Revenue and Growth Rate (2018-2023) Table Global Cancer Supportive Care Medicine Sales Forecast by Regions (2018-2023) Table Global Cancer Supportive Care Medicine Market Share Forecast by Regions (2018-2023) Figure North America Sales Cancer Supportive Care Medicine Market Forecast (2018-2023) Figure Europe Sales Cancer Supportive Care Medicine Market Forecast (2018-2023) Figure Asia-Pacific Sales Cancer Supportive Care Medicine Market Forecast (2018-2023) Figure South America Sales Cancer Supportive Care Medicine Market Forecast (2018-2023) Figure Middle East and Africa Sales Cancer Supportive Care Medicine Market Forecast (2018-2023) Table Global Cancer Supportive Care Medicine Sales Forecast by Type (2018-2023) Table Global Cancer Supportive Care Medicine Market Share Forecast by Type (2018-2023) Table Global Cancer Supportive Care Medicine Sales Forecast by Application (2018-2023) Table Global Cancer Supportive Care Medicine Market Share Forecast by Application (2018-2023) Table Distributors/Traders/ Dealers List

Amgen Helsinn Healthcare Johnson &Johnson Merck F. Hoffmann-La Roche GlaxoSmithKline Heron Therapeutics Kyowa Hakko Kirin Novartis TESARO Teva Pharmaceutical Industries